The development of a novel class of inhibitors for the enzyme autotaxin, that may find use for the treatment of idiopathic pulmonary fibrosis (IPF), was reported by Professor George Kokotos (Department of Chemistry, National and Kapodistrian University of Athens). According to the research data published in the peer-reviewed Journal of…